Comparing stem cell mobilization methods for lymphoma patients
Treatments studied
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial compares two ways to collect your own stem cells before a transplant in people with non-Hodgkin's lymphoma who are in remission. The goal is to see which method works better for getting enough healthy cells.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have non-Hodgkin's lymphoma and your doctor plans an autologous stem cell transplant.
- You are in complete remission after several rounds of chemotherapy.
- You are well enough to do daily activities (ECOG score 0 or 1).
- You have never had stem cells collected before.
- Your heart, liver, and kidneys are working well enough.
- You do not have an active infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two different combinations of medicines to help collect stem cells for a transplant in people newly diagnosed with multiple myeloma. The goal is to see which approach works better and is safer for you.
This trial tests a stem cell transplant with a special chemo combination (TEAM) to see if it can prevent lymphoma from coming back in the brain or spinal cord for people with high-risk non-Hodgkin lymphoma.
This Phase 2 study tests an auto (self) stem cell transplant for people with certain types of non-Hodgkin lymphoma or Hodgkin lymphoma who respond to chemotherapy (they are “chemo-sensitive”). It may help some patients get a deeper or longer remission by resetting the bone marrow after high-dose treatment.
This trial tests a modified chemotherapy conditioning regimen (called improved BEAM) before your own stem cell transplant for non-Hodgkin lymphoma. The goal is to see if the new regimen is safer and works as well as the standard approach, possibly with fewer side effects.
This trial compares using your own stem cells versus a donor's stem cells for a transplant to treat T-lymphoblastic leukemia or lymphoma after you've reached first remission. The goal is to see which approach works better to keep the disease from coming back.
This trial studies the best way to use an early (frontline) stem cell transplant for high-risk, CD20-positive diffuse large B-cell lymphoma (DLBCL). It aims to improve outcomes by comparing treatment approaches designed for people with a higher risk score.
Hear when a new Hematopoietic Stem Cell Mobilization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.